Shahid Beheshti University of Medical Sciences Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Tehran Iran (Islamic Republic of) (1959)

Organization Overview

First Clinical Trial
2001
NCT00555490
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Ali Amini Harandi | Associatec professor | Beheshti medical university | Cardiovascular research center, Modarres hospital, Shahid Beheshti University of Medical Sciences | Cardiovascular Research Center, Shaheed Beheshti Medical University, Tehran, Iran | Cardiovascular Research Center, Shahid Beheshti University of Medical Sciences. Tehran, Iran. | CKDRC,SBMU | Clinical Nutrition & Dietetics Dept., Shahid Beheshti University of Medical Sciences, | Clinical Research & Developement Center, Shahid Modares Hospital, Shahid Beheshti University (MC), Tehran, Iran | Clinical Research & Developement Center, Shahid Modares Hospital,Shahid Beheshti University (MC), Tehran, Iran | Clinical Research & Development Center, Shahid Modarres Hospital, Shahid Beheshti University (MC), Tehran, Iran | dental faculty of shaheed Beheshti medical university | Department of Clinical Nutrition and Diet Therapy, National Nutrition and Food Technology Research Institute, Faculty of Nutrition Sciences and Food Technology, Shahid Beheshti University of Medical Sciences | Department of Emergency Medicine, Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran. | Deputy of Research and Technology, Shahid Beheshti University of Medical Sciences | dr.dargahi | Faculty of Nutrition and Food Technology, SBMU | Faculty of Nutrition and Food Technology, Shahid Beheshti University of Medical Sciences, Tehran, Iran | Head of Neurosurgery research center of Shahid Beheshti University | Infectious Diseases and Tropical Medicine Research Center, Shaheed Beheshti Medical University, Tehran, Iran | Infertility and Reproductive health Research center, Imam Hossien hospital, Shahid Beheshti Medical university, Tehran, Iran | Javad Nasrollahzadeh | Labbafi Nejad Hospital, Shaheed Beheshti University of Medical Sciences, Tehran, Iran | Laboratory of Nutrition Research, National Nutrition and Food Technology Research Institute (NNFTRI) and Faculty of Nutrition Science and Food Technology, Shahid Beheshti University of Medical Sciences, Tehran, Iran | Lung Transplantation Research Center, National Research Institute of Tuberculosis and Lung Disease (NRITLD), Shahid Beheshti University of Medical Science, Tehran, Iran. | Lung Transplantation Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran | National Nutrition and Food Technology Research Institute Shahid Beheshti University of Medical Sciences, Tehran, Iran | National Nutrition & Food technology Research institute, Shaheed Beheshti University (M.C.), Islamic Republic of Iran, | National Research Institute of Tuberculosis and Lung Disease (NRITLD)-Shaheed Beheshti University of Medical Sciences | National Surgical Adjuvant Breast and Bowel Project Foundation, Inc. | nooshin dalili | NRITLD, Shahid Beheshti University of Medical Sciences | Ophthalmic Research Center of Shaheed Beheshti Medical University | Ophthalmic Research Center, Shaheed Beheshti Medical University | Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences | Ophthalmology research center, Shahid Beheshti University Of Medical Sciences | Postgraduate student of Shahid Beheshti Medicine University | praxisgemeinschaft für zelltherapie | Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti Medical University, Tehran, Iran | SBMU School of Pharmacy | SBMU School of Pharmacy, Tehran, Iran | Shaheed Beheshti Medical University | Shaheed Beheshti Medical Univrsity | Shaheed Beheshti University (MC) | Shaheed Beheshti University Of Medical Science | Shaheed Behesti Medical University | Shahid Beheshti Medical University | Shahid Beheshti University | Shahid Beheshti University (MC) | Shahid Beheshti university of medical science | Shahid Beheshti University of Medical Science | Shahid Beheshti University of Medical Sciences | Shahid Beheshti University of Medical Science _School of Traditional Medicine,Tehran ,Iran | Shahid Beheshti University of Medical Sciences, Tehran, Iran | Skin Research Center of Shaheed Beheshti medical University | Skin Research Center of Shaheed Beheshti Medical Universty | Skin Research Center of Shahid Beheshti medical University | Tracheal Diseases Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. | Urology and Nephrology Research Center, Shahid Beheshti University | Urology and Nephrology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran | Urology Nephrology Research Center, Labbafi Nejad Hospital, Shaheed Beheshti University of Medical Sciences, Tehran, Iran | Zahra Rabbani Khah

Active Ingredients

Drugs in Phase 4 Trials (21)

acetazolamide (diamox) (2 trials)

astragalus membranaceus (4 trials)

azithromycin (zithromax) (2 trials)

carbidopa (sinemet) (1 trial)

clindamycin (cleocin) (2 trials)

cyclosporine (sandimmune) (2 trials)

favipiravir (1 trial)

folic acid (1 trial)

gentamicin (garamycin) (1 trial)

heparin (liquaemin) (1 trial)

hydroxychloroquine (plaquenil) (5 trials)

interferon alpha-2b (Intron-A) (1 trial)

interferon beta-1b (betaseron) (1 trial)

levodopa (larodopa) (1 trial)

lopinavir (Kaletra) (4 trials)

peginterferon beta-1a (Plegridy) (3 trials)

ribavirin (virazole) (1 trial)

ritonavir (Norvir) (4 trials)

soybean (2 trials)

umifenovir (Arbidol) (1 trial)

vitamin d3 (8 trials)

Drugs in Phase 3 Trials (52)

acetylcysteine (mucomyst) (4 trials)

advax (5 trials)

aflibercept (zaltrap) (1 trial)

allogeneic mesenchymal stem cells (1 trial)

anti-staphylococcus bacteriophage therapy (1 trial)

bahman (1 trial)

betamethasone (celestone) (2 trials)

bevacizumab (avastin) (27 trials)

bisoprolol (zebeta) (1 trial)

colchicine (colbenemid) (3 trials)

covid19 recombinant spike protein (5 trials)

dorzolamide (trusopt) (1 trial)

doxycycline (vibramycin) (2 trials)

enoxaparin (lovenox) (2 trials)

epoetin (Epogen) (6 trials)

fasudil (3 trials)

fludrocortisone (florinef) (1 trial)

fluorouracil (efudex) (3 trials)

glucosamine (1 trial)

granisetron (kytril) (1 trial)

haloperidol (haldol) (1 trial)

icosapent ethyl (vascepa) (4 trials)

inactivated influenza vaccine (2 trials)

ketorolac (acuvail) (3 trials)

levocarnitine (carnitor) (1 trial)

l-glutamine (2 trials)

lorazepam (ativan) (1 trial)

maltodextrin (5 trials)

methotrexate (1 trial)

methylprednisolone (medrol) (1 trial)

metoclopramide (reglan) (1 trial)

midodrine (proamatine) (1 trial)

mitomycin (mutamycin) (6 trials)

mycophenolate (CellCept) (1 trial)

ondansetron (zofran) (1 trial)

oxygen (2 trials)

prednisolone (hydeltra) (2 trials)

prednisone (meticorten) (1 trial)

promethazine hydrochloride (phenergan) (3 trials)

propranolol (inderal) (1 trial)

pyrimethamine (daraprim) (1 trial)

rimabotulinumtoxinB (Myobloc) (1 trial)

sulfadiazine (1 trial)

sumatriptan (zecuity) (1 trial)

tacrolimus (prograf) (1 trial)

timolol (blocadren) (3 trials)

triamcinolone (kenalog) (16 trials)

urea (2 trials)

valproic acid (depakene) (1 trial)

verteporfin (visudyne) (1 trial)

vitamin c (1 trial)

vitis vinifera (1 trial)

Drugs in Phase 2 Trials (27)

a. digitata (1 trial)

allogenic mesenchymal stem cells derived exosome enriched by mir-124 (1 trial)

amantadine (symmetrel) (1 trial)

autologous cd133+ stem cells (1 trial)

calcium chloride (1 trial)

capecitabine (xeloda) (1 trial)

carbetocin (Pabal) (1 trial)

curcumin (3 trials)

diclofenac (voltaren) (3 trials)

garlic (2 trials)

ginger (2 trials)

insulin human (humulin) (2 trials)

interferon beta-1a (Avonex) (1 trial)

metformin (glucophage) (1 trial)

methylene blue (proveblue) (4 trials)

minocycline (minocin) (1 trial)

m. sylvestris (1 trial)

nystatin (mycostatin) (1 trial)

oxaliplatin (eloxatin) (1 trial)

oxytocin (syntocinon) (1 trial)

panitumumab (vectibix) (1 trial)

panthenol (1 trial)

platelet-rich plasma (1 trial)

sitagliptin (januvia) (2 trials)

tetracaine (pontocaine) (1 trial)

trichloroethanoic acid (1 trial)

vitamin a (1 trial)

Drugs in Phase 1 Trials (17)

allogeneic adipose derived mesenchymal stem cell (1 trial)

amniotic membrane (1 trial)

autologous mesenchymal stem cells (1 trial)

autologous muscle derived stem cells (1 trial)

buccal fat pad derived cells (1 trial)

citrulline (3 trials)

enalapril (vasotec) (1 trial)

human ezrin peptide (1 trial)

isotretinoin (Accutane) (1 trial)

naproxen (naprosyn) (1 trial)

omeprazole (prilosec) (1 trial)

phenytoin (mesantoin) (2 trials)

pilocarpine (ocusert) (1 trial)

potassium (1 trial)

pregabalin (lyrica) (1 trial)

umbilical cord mesenchymal stem cells (1 trial)

urtica dioica (1 trial)

Drugs in Other Trials (31)

acetylsalicylic acid (aspirin) (1 trial)

amoxicillin (1 trial)

barberry (1 trial)

bortezomib (velcade) (1 trial)

bovine colostrum (2 trials)

caraway seed (1 trial)

chia seed (1 trial)

clopidogrel (plavix) (1 trial)

conjugated linoleic acid (1 trial)

cumin (1 trial)

desmopressin (ddavp) (1 trial)

empagliflozin (jardiance) (2 trials)

everolimus (zortress) (1 trial)

flax (1 trial)

gel (1 trial)

lactobacillus rhamnosus (1 trial)

olive (1 trial)

omega-3 fatty acids (Omacor) (1 trial)

pentoxifylline (trental) (1 trial)

pimecrolimus (elidel) (1 trial)

platelet rich fibrin (1 trial)

quercetin (1 trial)

sodium chloride (3 trials)

spirulina (1 trial)

sunflower oil (1 trial)

surfactant (1 trial)

tea (1 trial)

triclosan (1 trial)

vitamin e (1 trial)

whey protein (1 trial)

zinc (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acne Vulgaris (Phase 2)

Acute Lung Injury (Phase 3)

Alzheimer Disease (Phase 2)

Amyotrophic Lateral Sclerosis (Phase 1)

Apnea (Phase 4)

Arteriosclerosis (Phase 3)

Arteriovenous Fistula (Phase 4)

Arthritis (Phase 1)

Arthritis, Rheumatoid (Phase 1)

Atrophy (Phase 2)

Brain Injuries (Phase 4)

Brain Injuries, Traumatic (Phase 4)

Carcinoma (Phase 2)

Carcinoma, Basal Cell (Phase 2)

Cardiomyopathies (Phase 4)

Cerebral Palsy (Phase 2)

Cerebrovascular Disorders (Phase 2)

Chickenpox (Phase 2)

Chorioretinitis (Phase 3)

Choroidal Neovascularization (Phase 3)

Communicable Diseases (Phase 1)

Coronary Artery Disease (Phase 3)

Coronary Disease (Phase 1)

Coronavirus Infections (Phase 1)

Critical Illness (Phase 3)

Diabetes Mellitus (Phase 1)

Diabetes Mellitus, Type 2 (Phase 2)

Diabetic Retinopathy (Phase 3)

Dizziness (Phase 3)

Edema (Phase 3)

Eisenmenger Complex (Phase 1)

Emphysema (Phase 1)

Endophthalmitis (Phase 4)

Eye Diseases (Phase 3)

Familial Primary Pulmonary Hypertension (Phase 1)

Fistula (Phase 4)

Glaucoma (Phase 3)

Heart Diseases (Phase 1)

Hemophilia A (Phase 4)

Hemorrhage (Phase 2)

Hepatitis (Phase 4)

Hepatitis A (Phase 4)

Hepatitis C (Phase 4)

Herpes Zoster (Phase 2)

Hyperlipidemias (Phase 3)

Hyperlipoproteinemias (Phase 3)

Hypertension (Phase 1)

Infections (Phase 2)

Infertility (Phase 3)

Infertility, Male (Phase 3)

Inflammation (Phase 4)

Ischemia (Phase 4)

Kidney Diseases (Phase 2)

Macular Degeneration (Phase 3)

Macular Edema (Phase 3)

Migraine Disorders (Phase 3)

Migraine with Aura (Phase 3)

Migraine without Aura (Phase 3)

Motor Neuron Disease (Phase 1)

Mucositis (Phase 2)

Multiple Organ Failure (Phase 3)

Myocardial Ischemia (Phase 3)

Myopia (Phase 1)

Necrosis (Phase 3)

Neoplasm Metastasis (Phase 2)

Neovascularization, Pathologic (Phase 3)

Optic Nerve Diseases (Phase 4)

Optic Nerve Injuries (Phase 2)

Optic Neuropathy, Ischemic (Phase 4)

Orbital Pseudotumor (Phase 3)

Overweight (Phase 3)

Paralysis (Phase 2)

Parkinson Disease (Phase 2)

Periapical Diseases (Phase 2)

Peripheral Nervous System Diseases (Phase 2)

Polycystic Ovary Syndrome (Phase 2)

Postpartum Hemorrhage (Phase 2)

Premature Birth (Phase 3)

Prostatic Neoplasms (Phase 2)

Psychomotor Agitation (Phase 3)

Pulmonary Emphysema (Phase 1)

Pyelonephritis (Phase 3)

Rectal Neoplasms (Phase 2)

Refractive Errors (Phase 1)

Respiratory Distress Syndrome (Phase 3)

Respiratory Distress Syndrome, Newborn (Phase 3)

Retinal Detachment (Phase 3)

Retinal Diseases (Phase 3)

Retinal Vein Occlusion (Phase 3)

Retinopathy of Prematurity (Phase 3)

Severe Acute Respiratory Syndrome (Phase 1)

Sleep Apnea, Central (Phase 4)

Sleep Apnea Syndromes (Phase 4)

Stomatitis (Phase 2)

Stomatitis, Denture (Phase 2)

Stroke (Phase 4)

Syncope (Phase 3)

Syncope, Vasovagal (Phase 3)

Syndrome (Phase 2)

Uveitis (Phase 1)

Vertigo (Phase 3)

Vitamin D Deficiency (Phase 4)

Vitreoretinopathy, Proliferative (Phase 3)

Wounds and Injuries (Phase 4)

Xerostomia (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 194
  • # of Trial APIs: 148